This new technology provides the first evidence of a chemotherapy drug reaching a glioblastoma.
This new technology provides the first evidence of a chemotherapy drug reaching a glioblastoma.
End of content
No more pages to load
From The Source
- Imugene: Bile Tract Cancer Patient maintains Complete Response in MAST Study for Over Two Years
- Recce: Phase II ABSSSI Clinical Trial Advances to Final Stages
- DoHAC: Landmark report on how to unleash the potential of our health professions
- Albanese Government indefinitely DEFERS patient access to 44 medicines on PBS – Better Access Australia
- DoHAC: Unleashing the Potential of our Health Workforce – Scope of Practice Review Final Report
- PenCS adds operations and financial module to Practice Cloud
- DoHAC: First year of Medicare data shows increase to bulk billing
- Designs unveiled for Cessnock Hospital Redevelopment
- $250 million New Griffith Base Hospital on track for completion in 2025
- Latest data reveals NSW’s top melanoma hotspots
- Vic: Medicinal Cannabis Driving Trial Starts
- COVID-19 Response Inquiry – Statement from the Doherty Institute